Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 170Neoplasms 129Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 31Neoplasm Metastasis 27Skin Neoplasms 26Liver Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Interventions

elemene 2Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Advanced Primary Liver Cancer × Clear all
NCT03167775 2017-05-30

Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer

BeiJing Yijiayi Medicine Techonoloy Co., Ltd.

Phase NA Unknown
30 enrolled

Advanced Primary Liver Cancer

NCT03166553 2017-05-25

Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer

BeiJing Yijiayi Medicine Techonoloy Co., Ltd.

Phase NA Unknown
150 enrolled

Advanced Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡